GGrantIndex
← Leaderboards

Brian M Peters

University Of Tennessee Health Sci Ctr

$4,952,404
Attributed
$7,382,493
Total exposure
8
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.2M · FY201625
$2.5M$1.9M$1.3M$625K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$7,382,493 · 8

By mechanism

R01$5,437,153 · 3
R21$1,677,500 · 4
K22$267,840 · 1

Top collaborators

Most similar at University Of Tennessee Health Sci Ctr

Same institution · by research overlap

Others in their field

Top investigators on “Fungus

Research focus

FungusAffectCandida AlbicansIn VivoMediatingInfectionInflammationImmune ResponseIn VitroImmunopathologyCandidaMouse ModelGeneticPathogenicityChronicImmunityNeutrophilCellsInterleukin-1 BetaMolecularInflammatoryPainQuality Of LifeSignal Transduction

Grant awards (20)

Fungal-bacterial dynamics driving dysregulated host responses and lethal synergism$785,881
R01 · FY2025 · AI · contact PI
Exploring the role, regulation, and antimicrobial function of Paneth cell peptides PYY and NPY in maintaining gut microbial commensalism and innate immune defense$686,064
R01 · FY2025 · DK
Candidalysin: a key mediator of Candida vaginitis immunopathology$441,284
R01 · FY2025 · AI · contact PI
Fungal-bacterial dynamics driving dysregulated host responses and lethal synergism$822,646
R01 · FY2024 · AI · contact PI
Exploring the role, regulation, and antimicrobial function of Paneth cell peptides PYY and NPY in maintaining gut microbial commensalism and innate immune defense$719,417
R01 · FY2024 · DK
Candidalysin: a key mediator of Candida vaginitis immunopathology$461,861
R01 · FY2024 · AI · contact PI
Genetic Determinants of Aspergillus host-pathogen interactions$192,500
R21 · FY2024 · AI
Genetic Determinants of Aspergillus host-pathogen interactions$231,000
R21 · FY2023 · AI
Lipid emulsion composition as a determinant of fungal biofilm formation and incidence of candidemia$190,000
R21 · FY2022 · AI · contact PI
Candidalysin: a key mediator of Candida vaginitis immunopathology$380,000
R01 · FY2021 · AI · contact PI
Lipid emulsion composition as a determinant of fungal biofilm formation and incidence of candidemia$228,000
R21 · FY2021 · AI · contact PI
Candidalysin: a key mediator of Candida vaginitis immunopathology$380,000
R01 · FY2020 · AI · contact PI
Targeted and forward genetic approaches to decipher the pathogenesis of symptomatic vulvovaginal candidiasis$228,000
R21 · FY2020 · AI · contact PI
Candidalysin: a key mediator of Candida vaginitis immunopathology$380,000
R01 · FY2019 · AI · contact PI
Sulfonylureas as repurposed agents against vulvovaginal candidiasis$190,000
R21 · FY2019 · AI · contact PI
Targeted and forward genetic approaches to decipher the pathogenesis of symptomatic vulvovaginal candidiasis$190,000
R21 · FY2019 · AI · contact PI
Candidalysin: a key mediator of Candida vaginitis immunopathology$380,000
R01 · FY2018 · AI · contact PI
Sulfonylureas as repurposed agents against vulvovaginal candidiasis$228,000
R21 · FY2018 · AI · contact PI
A novel role for the inflammasome in the immunopathogenesis of Candida vaginitis$108,000
K22 · FY2017 · AI · contact PI
A novel role for the inflammasome in the immunopathogenesis of Candida vaginitis$159,840
K22 · FY2016 · AI · contact PI